Davidson Kempner Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Davidson Kempner Capital Management’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-222,482	Closed	-$590K	–	240
2025 Q3	$590K	Hold	222,482	–	–	0.01%	183
2025 Q2	$219K	Hold	222,482	–	–	﹤0.01%	159
2025 Q1	$320K	Hold	222,482	–	–	﹤0.01%	162
2024 Q4	$489K	Hold	222,482	–	–	0.01%	156
2024 Q3	$367K	Hold	222,482	–	–	0.01%	144
2024 Q2	$489K	Hold	222,482	–	–	0.01%	178
2024 Q1	$594K	Hold	222,482	–	–	0.01%	173
2023 Q4	$663K	Hold	222,482	–	–	0.01%	149
2023 Q3	$219K	Hold	222,482	–	–	﹤0.01%	163
2023 Q2	$309K	Hold	222,482	–	–	0.01%	175
2023 Q1	$354K	Buy	+222,482	New	+$1.15M	0.01%	220

Other funds holding ESPR

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return